Can an experimental pill slow a rare brain disease? a trial puts ATH434 to the test.
Disease control
Not yet recruiting
This trial is investigating whether ATH434, an experimental drug taken twice daily as a tablet, can help control multiple system atrophy (MSA), a rare and progressive brain disorder. The study enrolls people who have already completed a prior phase 2 trial of ATH434 and may benef…
Phase: PHASE2 • Sponsor: Alterity Therapeutics • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC